Franklin Resources’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-57,039
Closed -$2.24M – 2845
2023
Q2
$2.24M Sell
57,039
-1,664,759
-97% -$58.8M ﹤0.01% 1369
2023
Q1
$41.9M Buy
1,721,798
+10,895
+0.6% +$239K 0.02% 575
2022
Q4
$36.6M Sell
1,710,903
-531
-0% -$11.3K 0.02% 609
2022
Q3
$30.7M Buy
1,711,434
+482,934
+39% +$6.34M 0.02% 666
2022
Q2
$11.8M Buy
1,228,500
+732
+0.1% +$9.19K 0.01% 912
2022
Q1
$20.7M Sell
1,227,768
-1,825
-0.1% -$27K 0.01% 849
2021
Q4
$20.6M Buy
1,229,593
+1,122,461
+1,048% +$18.4M 0.01% 884
2021
Q3
$1.74M Buy
+107,132
New +$1.17M ﹤0.01% 1494
2016
Q4
– Sell
-805,586
Closed -$37.2M – 1528
2016
Q3
$37.2M Sell
805,586
-343
-0% -$19.3K 0.02% 619
2016
Q2
$41.1M Buy
805,929
+218,227
+37% +$10.8M 0.02% 586
2016
Q1
$24.8M Buy
587,702
+80,930
+16% +$4.12M 0.01% 756
2015
Q4
$39.8M Sell
506,772
-65,200
-11% -$3.77M 0.02% 624
2015
Q3
$23.2M Buy
571,972
+343,225
+150% +$18.2M 0.01% 802
2015
Q2
$11.9M Buy
228,747
+9,089
+4% +$452K 0.01% 1001
2015
Q1
$10.2M Buy
219,658
+152,846
+229% +$7.93M ﹤0.01% 1048
2014
Q4
$3M Buy
+66,812
New +$2.81M ﹤0.01% 1264

Franklin Resources's ISEE Position: Q3 2023 in Review

Franklin Resources sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 57,039 shares — an estimated $2.24M sold.

Franklin Resources first reported a position in ISEE in Q4 2014 and held it in 16 quarters. The position peaked at $41.9M in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Franklin Resources reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Franklin Resources sold 57,039 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $2.24M.
  • Franklin Resources first reported a position in IVERIC bio, Inc. Common Stock in Q4 2014 and held it in 16 quarters.
  • Franklin Resources's IVERIC bio, Inc. Common Stock position peaked at $41.9M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Franklin Resources's 13F filing for Q3 2023, filed 13 Nov 2023.